A prominent member of the widely distributed class of guaianolides is arglabin, [1] which inhibits farnesyl transferase and thus activation of the RAS proto-oncogene, a process that is believed to play a pivotal role in 20-30 % of all human tumors. The natural product shows promising antitumor activity and cytotoxicity against different tumor cell lines (human tumor cell lines IC 50 = 0.9-5.0 mg mL À1 ). [2] Arglabin is isolated from Artemisia glabella and is transformed into the hydrochloride salt of the dimethylamino adduct 1·HCl to increase bioavailability. This compound 1·HCl has been successfully used in Kazakhstan for the treatment of breast, colon, ovarian, and lung cancers. [3,4] The heart of arglabin consists of a cycloheptane ring with five contiguous stereocenters, to which two five-membered rings are trans-annulated. The resulting strain can be released by ring opening of the g-butyrolactone at C-2, which makes arglabin and its derivatives prone to attack by nucleophilesa mode of action that plays an integral role in its biological activity. [2,5] The absence of other control factors should cause the planned epoxidation of 2 described in our retrosynthetic analysis (Scheme 1) to preferably occur from the top face of the tricycle to afford a less-strained but undesirable cis junction between the five-and seven-membered rings. Considering this, we reasoned that a hydroxy function at C-8 could direct a suitable epoxidation reagent to the desired lower face, and subsequently allow the installment of the double bond between C-8 and C-9 by elimination of water. Compound 2 should be accessible from 3 by allylation and subsequent ringclosing metathesis (RCM); the latter requires the formation of a tetrasubstituted double bond within a medium-sized seven-membered ring. Following the strategy developed in our research group for the enantioselective synthesis of trans-4,5-disubstituted g-butyrolactones, [6,7] the allylation of cyclopropane 4 with the allylsilane 5 should lead to the first key intermediate 3.Cyclopropanecarbaldehyde 8 was prepared in diastereoand enantiomerically pure form in two steps from methyl-2-furoate (6) on a 50 g scale (Scheme 2) following an analogous Scheme 1. Retrosynthetic analysis of arglabin. PG = protecting group, TMS = trimethylsilyl.Scheme 2. a) 1. Ethyl diazoacetate (2.67 equiv), Cu(OTf) 2 (0.66 mol %), (R,R)-iPr-box [8] (0.84 mol %), PhNHNH 2 (0.70 mol %), CH 2 Cl 2 , 85-90 % ee; 2. recrystallization (pentane), > 99 % ee, 38%; b) 1. O 3 , CH 2 Cl 2 , À78 8C 2. dimethylsulfide, 94 %; c) CH 3 MgCl, TMSCl, CuI, LiCl, THF, À78 8C, 4 h, 90 %; d) TMSCH 2 MgCl, [Ni(acac) 2 ], Et 2 O, reflux, 16 h, 72 %. Tf = trifluoromethanesulfonyl, acac = acetylacetonate, PMB = para-methoxybenzyl.